Global, regional, and country-level cost of leptospirosis due to loss of productivity in humans.

ABSTRACT:

Background

Leptospirosis, a prevalent zoonotic disease with One Health priority and a disease of poverty, lacks global economic burden estimates. This study aims to determine the global, regional, and country-level cost of leptospirosis due to loss of productivity.

Methodology/principal findings

The cost of leptospirosis due to loss of productivity (referred to as productivity cost hereafter) was estimated by converting the disability-adjusted life years (DALYs) lost due to leptospirosis to a monetary value using the per capita gross domestic product (GDP). The country-specific DALYs lost were obtained from the global burden of leptospirosis study published previously. Non-health GDP per capita (GDP- per capita health expenditure) was used for the cost conversion of DALYs. C

SUBMITTER: Agampodi S 

PROVIDER: S-EPMC10482283 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature